Alx Oncology Holdings (ALXO) Other Non-Current Assets (2019 - 2026)

Alx Oncology Holdings has reported Other Non-Current Assets for 8 years, with the latest figure at $2.9 million in Q1 2026.

• Quarterly Other Non-Current Assets fell 54.94% year-over-year to $2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.9 million (down 54.94% YoY) and the FY2025 annual result came in at $149000.0, down 97.87% from the prior year.
• Other Non-Current Assets improved to $2.9 million in Q1 2026 per ALXO's latest filing, from $149000.0 in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $16.3 million in Q3 2022 and troughed at $66000.0 in Q2 2022.
• A 5-year average of $8.2 million and a median of $9.0 million in 2025 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets tumbled 99.25% in 2022, then jumped 9827.78% in 2024.
• Over 5 years, Other Non-Current Assets stood at $14.9 million in 2022, then decreased by 0.25% to $14.9 million in 2023, then plunged by 53.04% to $7.0 million in 2024, then plunged by 97.87% to $149000.0 in 2025, then surged by 1867.11% to $2.9 million in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $2.9 million, $149000.0, and $9.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.